[Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients].

医学 HBeAg 聚乙二醇干扰素 内科学 胃肠病学 血清转化 乙型肝炎表面抗原 乙型肝炎 置信区间 α-干扰素 随机对照试验 乙型肝炎病毒 慢性肝炎 免疫学 干扰素 抗体 病毒 利巴韦林
作者
Feng-Qin Hou,Yulong Yin,Li Zeng,Jing Shang,Gaoming Gong,Chunqin Pan,Mingxiang Zhang,Chibiao Yin,Qing Xie,Yiqiang Peng,Shengli Chen,Qing Mao,Ya Chen,Mao Qian-guo,D Z Zhang,Tao Han,M R Wang,Weiming Zhao,Jingbang Liu,Ying Han
出处
期刊:PubMed [National Institutes of Health]
卷期号:25 (8): 589-596 被引量:13
标识
DOI:10.3760/cma.j.issn.1007-3418.2017.08.007
摘要

Objective: To investigate the clinical effect and safety of long-acting pegylated interferon-α-2b (Peg-IFN-α-2b) (Y shape, 40 kD) injection (180 μg/week) in the treatment of HBeAg-positive chronic hepatitis B (CHB) patients, with standard-dose Peg-IFN-α-2a as positive control. Methods: This study was a multicenter, randomized, open-label, and positive-controlled phase III clinical trial. Eligible HBeAg-positive CHB patients were screened out and randomized to Peg-IFN-α-2b (Y shape, 40 kD) trial group and Peg-IFN-α-2a control group at a ratio of 2:1. The course of treatment was 48 weeks and the patients were followed up for 24 weeks after drug withdrawal. Plasma samples were collected at screening, baseline, and 12, 24, 36, 48, 60, and 72 weeks for centralized detection. COBAS® Ampliprep/COBAS® TaqMan® HBV Test was used to measure HBV DNA level by quantitative real-time PCR. Electrochemiluminescence immunoassay with Elecsys kit was used to measure HBV markers (HBsAg, anti-HBs, HBeAg, anti-HBe). Adverse events were recorded in detail. The primary outcome measure was HBeAg seroconversion rate after the 24-week follow-up, and non-inferiority was also tested. The difference in HBeAg seroconversion rate after treatment between the trial group and the control group and two-sided confidence interval (CI) were calculated, and non-inferiority was demonstrated if the lower limit of 95% CI was > -10%. The t-test, chi-square test, or rank sum test was used according to the types and features of data. Results: A total of 855 HBeAg-positive CHB patients were enrolled and 820 of them received treatment (538 in the trial group and 282 in the control group). The data of the full analysis set showed that HBeAg seroconversion rate at week 72 was 27.32% in the trial group and 22.70% in the control group with a rate difference of 4.63% (95% CI -1.54% to 10.80%, P = 0.1493). The data of the per-protocol set showed that HBeAg seroconversion rate at week 72 was 30.75% in the trial group and 27.14% in the control group with a rate difference of 3.61% (95% CI -3.87% to 11.09%, P = 0.3436). 95% CI met the non-inferiority criteria, and the trial group was non-inferior to the control group. The two groups had similar incidence rates of adverse events, serious adverse events, and common adverse events. Conclusion: In Peg-IFN-α regimen for HBeAg-positive CHB patients, the new drug Peg-IFN-α-2b (Y shape, 40 kD) has comparable effect and safety to the control drug Peg-IFN-α-2a.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小黑关注了科研通微信公众号
刚刚
绿豆酥发布了新的文献求助10
1秒前
wxz1236发布了新的文献求助10
1秒前
1秒前
吴宗翰完成签到,获得积分10
1秒前
1秒前
2秒前
kkk发布了新的文献求助10
2秒前
长情外绣完成签到,获得积分10
2秒前
运气好点吧完成签到,获得积分10
3秒前
栈逸完成签到,获得积分10
3秒前
3秒前
英姑的应助被贝肯帕尼尼采纳,获得10
3秒前
4秒前
彪壮的凝海完成签到,获得积分10
4秒前
hhh完成签到,获得积分10
4秒前
桐桐的应助被精明的笑珊采纳,获得10
4秒前
赘婿的应助被科研通管家采纳,获得10
5秒前
5秒前
上官若男的应助被科研通管家采纳,获得30
5秒前
英姑的应助被科研通管家采纳,获得50
5秒前
5秒前
5秒前
5秒前
5秒前
Jasper的应助被UU采纳,获得10
5秒前
大模型的应助被科研通管家采纳,获得10
5秒前
5秒前
CipherSage的应助被科研通管家采纳,获得10
5秒前
5秒前
无花果的应助被科研通管家采纳,获得50
5秒前
ding的应助被kelite采纳,获得10
5秒前
FashionBoy的应助被科研通管家采纳,获得10
6秒前
完美世界的应助被kelite采纳,获得10
6秒前
NexusExplorer的应助被科研通管家采纳,获得10
6秒前
思源的应助被kelite采纳,获得10
6秒前
6秒前
小马甲的应助被科研通管家采纳,获得10
6秒前
赘婿的应助被kelite采纳,获得10
6秒前
ding的应助被科研通管家采纳,获得10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8191812
求助须知:如何正确求助?哪些是违规求助? 9578503
关于积分的说明 21859856
捐赠科研通 7791184
什么是DOI,文献DOI怎么找? 3436733
关于科研通互助平台的介绍 2560447
邀请新用户注册赠送积分活动 2483502